IN2012DN06279A - - Google Patents

Info

Publication number
IN2012DN06279A
IN2012DN06279A IN6279DEN2012A IN2012DN06279A IN 2012DN06279 A IN2012DN06279 A IN 2012DN06279A IN 6279DEN2012 A IN6279DEN2012 A IN 6279DEN2012A IN 2012DN06279 A IN2012DN06279 A IN 2012DN06279A
Authority
IN
India
Prior art keywords
rosacea
receptor
cxcl5
chemokines
interleukin
Prior art date
Application number
Other languages
English (en)
Inventor
Jérôme Aubert
Martin Steinhoff
Michel Rivier
Johannes Voegel
Original Assignee
Galderma Res & Dev
Uni Munster
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galderma Res & Dev, Uni Munster filed Critical Galderma Res & Dev
Publication of IN2012DN06279A publication Critical patent/IN2012DN06279A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • G01N33/6869Interleukin
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
IN6279DEN2012 2009-12-17 2010-12-16 IN2012DN06279A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US28211309P 2009-12-17 2009-12-17
PCT/EP2010/069896 WO2011073321A1 (fr) 2009-12-17 2010-12-16 Marqueurs et procédé de diagnostic de la rosacée

Publications (1)

Publication Number Publication Date
IN2012DN06279A true IN2012DN06279A (fr) 2015-09-25

Family

ID=43417037

Family Applications (1)

Application Number Title Priority Date Filing Date
IN6279DEN2012 IN2012DN06279A (fr) 2009-12-17 2010-12-16

Country Status (12)

Country Link
US (1) US20130017969A1 (fr)
EP (1) EP2513328A1 (fr)
JP (1) JP2013514070A (fr)
KR (1) KR20120115321A (fr)
CN (1) CN102762742A (fr)
AU (1) AU2010332876A1 (fr)
BR (1) BR112012014678A2 (fr)
CA (1) CA2783693A1 (fr)
IN (1) IN2012DN06279A (fr)
MX (1) MX2012006623A (fr)
RU (1) RU2012130069A (fr)
WO (1) WO2011073321A1 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10370714B2 (en) 2011-06-27 2019-08-06 Galderma Research & Development Th-17 differentiation markers for rosacea and uses thereof
EP2723892A2 (fr) * 2011-06-27 2014-04-30 Galderma Research & Development Nouveaux marqueurs de différenciationth7 pour la rosacée et utilisations de ces derniers
CA2852160A1 (fr) * 2011-10-28 2013-05-02 Galderma Research & Development Nouveaux marqueurs d'infiltrat leucocytaire de rosacee et utilisations de ceux-ci
EP2791354B1 (fr) 2011-12-16 2017-06-14 Galderma Research & Development Procédé pour le diagnostic de l'acné rosacée
US9860241B2 (en) * 2014-04-15 2018-01-02 Level 3 Communications, Llc Device registration, authentication, and authorization system and method
KR101712747B1 (ko) 2015-11-06 2017-03-07 가톨릭대학교 산학협력단 유파틸린을 유효성분으로 포함하는 피부질환 예방 또는 치료용 조성물
CN106119348B (zh) * 2016-06-27 2018-02-23 中南大学湘雅医院 一种以非编码lnc‑CXCL1及编码基因cxcl1组合为检测或诊断筛查标志物的重症肌无力检测试剂盒及应用
KR102216941B1 (ko) * 2020-08-12 2021-02-18 주식회사 큐티스의생명연구센터 마이크로니들 패치를 포함하는 최소 침습적 홍조성 민감피부 평가 키트 및 홍조성 민감피부 평가를 위한 바이오마커
US20230304091A1 (en) * 2020-08-10 2023-09-28 Cutis Biomedical Research Center Minimally invasive kit for diagnosing skin condition, comprising microneedle patch
CN113462770B (zh) * 2021-08-25 2023-03-31 中国医科大学附属第一医院 趋化因子作为玫瑰痤疮诊断的分子标志物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090118141A1 (en) * 2005-05-04 2009-05-07 The Regents Of The University Of California Methods of oligosaccharide profiling for the detection of ocular rosacea
EP2124058B1 (fr) * 2006-01-05 2014-03-05 Galderma Research & Development Méthode de diagnostic basée sur des biomarqueurs de lésions acnéiques et procédé de criblage de leurs modulateurs
EP2069377A4 (fr) * 2006-09-27 2009-11-11 Univ California Procédés et compositions pour le traitement de maladies et de troubles de la peau
EP2212442A1 (fr) 2007-10-26 2010-08-04 Galderma Research & Development Procédé non invasif pour études pharmaco-génomiques de maladies inflammatoires cutanées et leur procédé de diagnostic
FR2923610B1 (fr) 2007-11-14 2009-11-27 Galderma Res & Dev Methode non-invasive de recueil de donnees biologiques pour l'etablissement d'un diagnostic d'une pathologie cutanee.

Also Published As

Publication number Publication date
JP2013514070A (ja) 2013-04-25
CN102762742A (zh) 2012-10-31
EP2513328A1 (fr) 2012-10-24
MX2012006623A (es) 2012-11-30
AU2010332876A1 (en) 2012-07-12
BR112012014678A2 (pt) 2016-04-05
US20130017969A1 (en) 2013-01-17
CA2783693A1 (fr) 2011-06-23
KR20120115321A (ko) 2012-10-17
WO2011073321A1 (fr) 2011-06-23
RU2012130069A (ru) 2014-01-27

Similar Documents

Publication Publication Date Title
IN2012DN06279A (fr)
MX2010003139A (es) Agentes terapeuticos para la enfermedad de injerto contra hospedero que comprenden un inhibidor del receptor de interleucina 6 como ingrediente activo.
MX2019013922A (es) Inhibidores novedosos de map4k1.
MX352614B (es) Nuevos agentes anti-inflamatorios.
NZ742819A (en) Inhibitors of cxcr2
UA103634C2 (en) Azaindazole compounds as ccr1 receptor antagonists
EA201171074A1 (ru) Цитотоксические конъюгаты с соединением, связывающим рецептор нейропептида y
EA200970051A1 (ru) Антагонист рецептора il-8
ECSP11011433A (es) Fenilureas y fenilamidas sustituidas como ligandos del receptor de vanilloides
CR10379A (es) Composiones farmaceuticas de antagonistas del anticuerpo anti-cd40.
EA201201541A1 (ru) НОВЫЕ ПРОИЗВОДНЫЕ ЦИКЛОГЕКСИЛАМИНА, ОБЛАДАЮЩИЕ АГОНИСТИЧЕСКОЙ АКТИВНОСТЬЮ ПО ОТНОШЕНИЮ К β2 АДРЕНЕРГИЧЕСКОМУ РЕЦЕПТОРУ И АНТАГОНИСТИЧЕСКОЙ АКТИВНОСТЬЮ ПО ОТНОШЕНИЮ К M3 МУСКАРИНОВОМУ РЕЦЕПТОРУ
CL2014001452A1 (es) Compuestos derivados de dihidro-benzo-oxacina y dihidro-pirido-oxacina; composicion farmaceutica; metodo para modular la actividad de enzimas pi3k; metodo para el tratamiento; y uso para el tratamiento de artritis reumatoide, pénfigo vulgar, esclerosis multiple, miastenia grave, alergia y malaria, entre otras enfermedades.
WO2011154139A3 (fr) Marqueurs d'expression génique pour la prédiction d'une réponse à un traitement par un médicament anticorps monoclonal inhibant le récepteur de l'interleukine-6
SG154441A1 (en) Treatment of demyelinating disorders
WO2010044543A3 (fr) Composé hétérocyclique utilisé comme inhibiteur de la protéine kinase
WO2012103360A3 (fr) Compositions de wnt et procédés d'utilisation de celles-ci
WO2007108936A3 (fr) Azacyclylamines avec substitution n en tant qu'antagonistes de l'histamine-3
WO2010112458A8 (fr) Composition et procédés d'utilisation d'anticorps thérapeutiques spécifiques du sous-motif bêta-1 des récepteurs d'il-12
MX2010006089A (es) Metodos de tratamiento de enfermedad pulmonar obstructiva cronica.
WO2007136668A3 (fr) N-benzoyle et n-benzylpyrrolidin-3-ylamines comme antagonistes de l'histamine-3
WO2007015157A3 (fr) Nouvelles utilisations de composes d'agonistes du recepteur de mc4
MX2011012669A (es) Nuevos agonistas del receptor de glucocorticoides.
UA102231C2 (ru) Применение фипронила для увеличения урожайности пшеницы и способ обработки пшеницы
EA201001842A1 (ru) Новые соединения, обладающие активностью антагонистов мускариновых рецепторов
TNSN07462A1 (en) Ampa receptor potentiators